← All Sponsors
SPONSOR

Processa Pharmaceuticals

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Breast CancerTNBC - Triple-Negative Breast CancerHER2-negative Breast Cancer
NCT06568692 Phase 2
Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Breast Cancer
United States View Trial →